A clinical trial usually involves many different parties, who are not always used to communicating with each other: study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs and so on. Lack of communication can cause misunderstandings if a party is not informed of the latest data, potentially leading to patient risk.
With a single source of truth, each collaborator can transparently access the latest clinical forecasts as well as up-to-date data including enrollment and dropout rate, titrations probabilities, future productions, etc. The reliability of this information is a must as it plays a fundamental role in the clinical supply strategy, as well as planning including distribution, packaging, manufacturing and sampling.
If everyone agrees on the source of truth, the resulting forecasts can legitimately be used across the organization for resource planning activities, decision-making, vendor management, etc. through strategic visualization dashboards.
Amaury Jeandrain
Head of Solutions Adoption, Life Sciences
Amaury holds a Master’s Degree in Business Engineering with a specialization in supply chain management. After working for a contract research organization (CRO), he joined N-SIDE where he supported the optimization of hundreds of trials from different indications and pharmaceutical companies, providing services ranging from risk-based optimization to clinical trial design and solving drug supply shortage problems. Amaury now leads a group of consultants, focusing on the extension of N-SIDE’s solutions.
Pauline Deplasse
Senior Consultant, Life Sciences
Pauline joined N-SIDE as a consultant and has since been helping their partners make better and more informed decisions on their clinical trial supply. She has accompanied a growing number of companies in their adoption of N-SIDE’s consulting services and solutions. As a curious problem solver, she thrives in challenging projects. Pauline holds a Master in Business Engineering and has extensive international experience.